These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [TBL] [Abstract][Full Text] [Related]
23. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study. Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C; J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Kiely P; Margaritis AR; Seed CR; Yang H; Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170 [TBL] [Abstract][Full Text] [Related]
25. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191 [TBL] [Abstract][Full Text] [Related]
26. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP; Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ; J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus infection--natural history and clinical consequences. Ganem D; Prince AM N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185 [No Abstract] [Full Text] [Related]
30. Acute hepatitis B virus infection with simultaneous high HBsAg and high anti-HBs signals in a previously HBV vaccinated HIV-1 positive patient. van Dommelen L; Verbon A; van Doorn HR; Goossens VJ J Clin Virol; 2010 Mar; 47(3):293-6. PubMed ID: 20060779 [TBL] [Abstract][Full Text] [Related]
31. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus. Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280 [TBL] [Abstract][Full Text] [Related]
32. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa. Chotun N; Nel E; Cotton MF; Preiser W; Andersson MI Vaccine; 2015 Aug; 33(36):4618-22. PubMed ID: 26163924 [TBL] [Abstract][Full Text] [Related]
36. Occult hepatitis B virus infection in Japanese chronic hemodialysis patients. Nagakawa O; Miyatomi Y; Shigeta Y; Inayama E; Murakami K; Sakai T; Kouno T; Masai M; Shirai K; Yoshida T Ther Apher Dial; 2013 Jun; 17(3):289-92. PubMed ID: 23735143 [TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen. Ramia S; Mokhbat J; Ramlawi F; El-Zaatari M Int J STD AIDS; 2008 Mar; 19(3):197-9. PubMed ID: 18397562 [TBL] [Abstract][Full Text] [Related]
38. Occult infection with HBV intergenotypic A2/G recombinant following acute hepatitis B caused by an HBV/A2 isolate. de Barros JJ; Peres LR; de Sousa PS; do Amaral Mello FC; de Araujo NM; de Andrade Gomes S; Niel C; Lewis-Ximenez LL J Clin Virol; 2015 Jun; 67():31-5. PubMed ID: 25959154 [TBL] [Abstract][Full Text] [Related]
39. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029 [TBL] [Abstract][Full Text] [Related]
40. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?]. Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]